However, this conclusion is clinically contra-intuitive because we and others have noted that BRCA1 mutation carriers (predominating among our mutation-positive patients) are mostly young, TNBC patients who otherwise represent a subpopulation of BC patients with poor prognoses [23,24,25]. This evidence concerns the gene BRCA1 and breast cancer.